Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

444
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
444
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

697
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
697
Pharmacodynamics: Overview and Principles01:21

Pharmacodynamics: Overview and Principles

1.0K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
1.0K
Pharmacokinetics: Overview01:10

Pharmacokinetics: Overview

6.2K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
6.2K
Three-Compartment Open Model01:06

Three-Compartment Open Model

187
The three-compartment open model is a pharmacokinetic model used to describe the distribution and elimination of drugs following extravascular administration. It comprises a central compartment representing the plasma and two peripheral compartments. The highly perfused peripheral compartment represents organs and tissues with a rich blood supply, such as the liver, kidneys, and lungs. The scarcely perfused peripheral compartment represents tissues with lower blood supply, such as adipose...
187
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

1.9K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Need for Unification: Assessing Variability in Top 200/300 Drug Lists at 7 Schools of Pharmacy.

American journal of pharmaceutical education·2026
Same author

Exploring Early-Learner Discoveries and Impacts Through Thematic Coding of Qualitative Reflections to Interprofessional Competencies.

American journal of pharmaceutical education·2025
Same author

Strengthening Interprofessional Education Plan Evaluation Through Evidence-Based Practices.

American journal of pharmaceutical education·2025
Same author

Glucagon-like Peptide-1 Receptor Agonists and Reproductive Health: Current Evidence and Clinical Implications.

Journal of pharmacy practice·2025
Same author

Description of a Longitudinal Interprofessional Education Plan and Outcomes From an Inaugural Student Cohort.

American journal of pharmaceutical education·2024
Same author

Assessment of Patient Care Activities and Readiness for Advanced Pharmacy Practice Experiences in Revised Third-Year Introductory Pharmacy Practice Experiences.

American journal of pharmaceutical education·2024

Related Experiment Video

Updated: Jun 20, 2025

Improving Student Outcomes with an Adaptable Molecular Cloning Course-Based Undergraduate Research Experience
10:17

Improving Student Outcomes with an Adaptable Molecular Cloning Course-Based Undergraduate Research Experience

Published on: November 15, 2024

1000

Rational Redesign of an Introductory Pharmacy Practice Experience Curriculum.

Susanne G Barnett1, Andrea L Porter1, Marina L Maes1

  • 1University of Wisconsin-Madison School of Pharmacy, Madison, WI, USA.

American Journal of Pharmaceutical Education
|July 18, 2024
PubMed
Summary
This summary is machine-generated.

A systematic quality improvement process revised an introductory pharmacy practice experience (IPPE) curriculum by incorporating stakeholder feedback. This process identified and addressed curriculum weaknesses while retaining strengths for future pharmacy education.

Keywords:
Curricular revisionCurriculum redesignExperiential educationIntroductory pharmacy practice experienceStakeholders

More Related Videos

Setup and Execution of the Rapid Cycle Deliberate Practice Death Notification Curriculum
04:36

Setup and Execution of the Rapid Cycle Deliberate Practice Death Notification Curriculum

Published on: August 5, 2020

4.2K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K

Related Experiment Videos

Last Updated: Jun 20, 2025

Improving Student Outcomes with an Adaptable Molecular Cloning Course-Based Undergraduate Research Experience
10:17

Improving Student Outcomes with an Adaptable Molecular Cloning Course-Based Undergraduate Research Experience

Published on: November 15, 2024

1000
Setup and Execution of the Rapid Cycle Deliberate Practice Death Notification Curriculum
04:36

Setup and Execution of the Rapid Cycle Deliberate Practice Death Notification Curriculum

Published on: August 5, 2020

4.2K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K

Area of Science:

  • Pharmacy Education
  • Curriculum Development
  • Quality Improvement

Background:

  • Introductory Pharmacy Practice Experience (IPPE) curricula are crucial for foundational pharmacy skills.
  • Stakeholder perspectives are vital for effective curriculum design and revision.

Purpose of the Study:

  • To implement a systematic process for identifying strengths and weaknesses in an IPPE curriculum.
  • To revise the IPPE curriculum based on stakeholder feedback and quality improvement principles.

Main Methods:

  • A 5-step quality improvement process was developed and applied by a dedicated taskforce.
  • Stakeholder feedback was gathered through surveys, focus groups, and meetings.
  • Quantitative data were analyzed using descriptive statistics, and qualitative data underwent inductive content analysis.

Main Results:

  • Students desired fewer scheduling negotiations, reduced conflicts with class time, and more direct patient care.
  • Structural changes included shifting IPPE hours to the third year and optimizing scheduling.
  • Content was enhanced through curricular mapping, threading, and inter-coordinator collaboration.

Conclusions:

  • A 5-step systematic process effectively revised the IPPE curriculum by integrating stakeholder input.
  • This methodology can be adopted by other pharmacy programs for their IPPE curriculum redesign.